期刊文献+

米力农与多巴酚丁胺治疗重度充血性心力衰竭的疗效比较 被引量:1

下载PDF
导出
摘要 目的:比较米力农与多巴酚丁胺治疗重度充血性心力衰竭的疗效。方法:将符合筛选标准的82例充血性心力衰竭患者随机分成治疗组和对照组各41例,两组常规应用强心、利尿、扩血管等治疗。治疗组加用米力农0.5μg/(kg.min),静脉维持共7 d;对照组加用多巴酚丁胺5μg/(kg.min),静脉维持共7 d。结果:治疗组临床有效23例(56%),对照组临床有效14例(34%)(P<0.05)。治疗组心脏左室射血分数(LVEF)、心脏指数(CI)、心输出量(CO)均显著优于对照组(P<0.05)。结论:与多巴酚丁胺对比,米力农在治疗重度充血性心力衰竭中的疗效更加确切安全。
作者 鄢飞奔
出处 《吉林医学》 CAS 2011年第35期7489-7490,共2页 Jilin Medical Journal
  • 相关文献

参考文献2

二级参考文献16

  • 1王凤,王继征,于平,冯磊,张国清.米力农联合单硝酸异山梨酯治疗重度充血性心衰近期疗效观察[J].山东医药,2006,46(19):56-57. 被引量:10
  • 2马洪林.米力农在慢性肺心病心力衰竭治疗中的作用[J].临床荟萃,2006,21(16):1197-1198. 被引量:10
  • 3陈树宝,李万镇,马沛然,钱永如,宁寿葆.小儿心力衰竭诊断与治疗建议[J].中华儿科杂志,2006,44(10):753-757. 被引量:111
  • 4Petersen JW,Felker GM. Inotropes in the management of acute heart failure[ J ]. Crit Care Med,2008,36 ( 1 suppl) : 106 - 111.
  • 5Chang AC, Atz AM, Wernovsky G, et al. Milrinone : Systemic and pulmonary hemo - dynamic effects in neonates after cardiac surgery [ J ]. Crit Care Med, 1995,23 ( 11 ) :1907 - 1914.
  • 6Gauthier N, Anselm AH, Haddad H. New therapies in acute decompensated heart failure [ J ]. Curr Opin Cardiol,2008,23 ( 2 ) : 134 - 140.
  • 7Hentsehel T, Yin N, Riad A, et al. Inhalation of the phosphodiesterase - 3 inhibitor milrinone attenuates pulmonary hypertension in a rat model of congestive heart failure[ J]. Anesthesiology,2007,106( 1 ) : 124 - 131.
  • 8Cai J, Su Z, Shi Z, et al. Nitric oxide in conjunction with milrinone better stabilized pulmonary hemodynamics after Fontan procedure [ J ]. Artif Organs,2008,32 ( 11 ) : 864 - 869.
  • 9Piamsomboon C, Tanaka KA, Szlam F, et al. Comparison of relaxation responses to multiple vasodilators in TxA(2) - analog and endothelin - 1 - precontracted pulmonary arteries [ J ]. Acta Anaesthesiol Scand, 2007,51 (6) :714 -721.
  • 10Orime Y, Shiono M, Hata H, et al. Effects of phosphodiesteras inhibitors after coronary artery bypass grafting [J]. Jpn Circ J, 1999, 63(2) : 117- 122.

共引文献17

同被引文献11

  • 1McMurray JJ, Adamopoulos S, Anker SD, et al. Esc guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the european society of cardiology, Developed in collaboration with the heart failure association (hfa) of the esc[J]. Eur J Heart Fail, 2012, 14(8): 803-869.
  • 2Yi GY, Li JX, Zhang J, et al. Repetitive infusion of levosimendan in patients with chronic heart failure: a meta-analysis[J]. Med Sci Monit, 2015, 21: 895-901.
  • 3Kelder JC, Cowie MR, McDonagh TA, et al. Quantifying the added value of BNP in suspected heart failure in general practice: an individual patient data meta-analysis[J]. Heart, 2011, 97(12): 959- 963.
  • 4Nieminen MS, Ahenberger J, Ben-Gal T, et al. Repetitive use of levosimendan for treatment of chronic advanced heart failure: clinical evidence, practical considerations, and perspectives: an expert panel consensus[J]. Int J Cardiol, 2014, 174(2): 360-367.
  • 5Papp Z, l~des I, Fruhwald S, et al. Levosimendan: molecular mechanisms and clinical implications: consensus of experts on themechanisms of action of levosimendan[J]. Int J Cardiol, 2012, 159 (2): 82-87.
  • 6Silvetti S, Greco T, Di Prima AL, et al. Intermittent levosimendan improves mid-term survival in chronic heart failure patients: meta- analysis of randomised trials[J]. Clin Res Cardiol, 2014, 103(7): 505-513. DOE 10.1007/s00392-013-0649-z.
  • 7黄俊玲,罗明.心力衰竭部分药物治疗的循证医学新进展[J].国际心血管病杂志,2011,38(1):30-33. 被引量:16
  • 8杜贺,史承勇,陈少萍.左西孟旦的研究新进展[J].中国循环杂志,2014,29(7):555-557. 被引量:66
  • 9郝国贞,高恒波,范卫泽,杨静静,汪雁博,姜云发,谷新顺,傅向华.左西孟旦治疗老年慢性心力衰竭的效果与安全性评价[J].中国全科医学,2015,18(26):3153-3157. 被引量:54
  • 10牡兰,陶谢鑫,于影.左西孟旦治疗心力衰竭临床研究新进展[J].内蒙古民族大学学报(自然科学版),2015,30(2):152-155. 被引量:14

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部